Company: MDXG
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001376339-25-000048
Chunk: 57

Company: MIMEDX GROUP, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 57
---
7, respectively.14,282will vest on March 13, 2026.32,488RSUs will vest on March 1, 2027.                                                                                                                              |

#### 2024 Option Exercises and Stock Vested Table
The following table provides information concerning each exercise of stock options and each vesting of RSUs during 2024, on an aggregated basis with respect to each of the Company’s NEOs.

| Name                   |     | Stock Awards                             
 Number of Securities Acquired on Vesting |     |         |     | Value Realized on Vesting |           |
|:-----------------------|:----|:-----------------------------------------|:----|--------:|:----|:--------------------------|----------:|
| Joseph H. Capper       |     |                                          |     |       — |     | $                         |         — |
| Doug Rice              |     |                                          |     |  32,400 |     | $                         |   219,996 |
| William F. Hulse IV    |     |                                          |     | 138,079 |     | $                         | 1,043,705 |
| Ricci S. Whitlow       |     |                                          |     | 154,285 |     | $                         | 1,247,008 |
| Kimberly Maersk-Moller |     |                                          |     |  41,910 |     | $                         |   336,731 |

| 1 |     | Represents the number of shares acquired on vesting multiplied by closing price of Company common stock on the vesting date. Vesting occurred in accordance with applicable restricted stock unit agreements with the Company, pursuant to Section 10.02 of the 2016 Plan. |

<div align='center'>33

2024 Potential Payments Upon Termination Or Change In Control</div>

This section describes additional payments that the Company would make to the NEOs assuming a hypothetical termination of employment occurred on December 31, 2024 under various scenarios.

#### No-Cause Termination
The Company entered into an Executive Retention Agreement with each NEO that provides for compensation to the executive in the event the executive’s employment with the Company is terminated involuntarily without “Cause” (as defined in the agreement), or if the executive voluntarily terminates employment for “Good Reason” (as defined in the agreement) prior to a “change-in-control.” The compensation payable under the agreements is a lump sum severance payment equal to a multiple of the executive’s annual base salary